Blue Cross Blue Shield settled a 2.67 billion antitrust lawsuit in 2020 after restricting competition for more than a decade. Payments begin in 2026. Six years later, customers get checks while insurers move on. Here is what happened and why it keeps happening.

UnitedHealth dropping Medicare Advantage plans for 600000 beneficiaries exposes a structural flaw in how private insurers manage public healthcare risk as costs from emergency care and specialty drugs accelerate faster than payment models can adjust.

Health systems consolidate. Insurers post record profits. Employers spend $20,000 per employee on coverage while workers fight denials alone at 11 pm. Insurance middlemen now cost more than the drugs. The system rewards delay and calls it complexity. Families call it Tuesday.

Mount Sinai and Anthem fight over 450 million dollars while 200000 patients scramble to keep their doctors and cancer treatment. Corporate contract disputes now function as leverage tactics, turning patients into bargaining chips in rate negotiations.

A personal reflection on Gil Bashe’s Healing the Sick Care System and the growing revolt against insurance driven harm. From hospital memories to national accountability, this piece calls out who holds the wheel and why 2026 signals the rise of the patient voter bloc.

Blue Cross Blue Shield says insurers protect patients from high drug prices. The real world shows delays, denials, and blame shifting while patients wait, appeal, and deteriorate. A closer look at how insurers deflect responsibility in the drug pricing debate.

Insurance companies promise reform while patients absorb delay and denial. From IVIG rejections to cancer imaging hold ups, this essay documents how prior authorization functions in real life and why patients now recognize the pattern.

An open letter to Mark Cuban on why the Great Healthcare Plan fails patients. It leaves PBM power intact, ignores pricing abuse, and turns transparency into theater. Patients already know how often claims get denied. We live it every day.

After surviving brain cancer at 21, Matthew Zachary examines how modern healthcare policy repackages risk as freedom. From cash subsidies to math free promises, this essay exposes why consumer style healthcare fails the moment illness enters the room.

Marc Elia chairs a biotech company and lives with Long COVID. On Out of Patients, he breaks down the invisible immunocompromised population, the limits of regulatory thinking, and why empathy without action leaves patients stranded.